We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Gear Up for DexCom (DXCM) Q1 Earnings: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
The upcoming report from DexCom (DXCM - Free Report) is expected to reveal quarterly earnings of $0.33 per share, indicating an increase of 3.1% compared to the year-ago period. Analysts forecast revenues of $1.02 billion, representing an increase of 10.3% year over year.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
With that in mind, let's delve into the average projections of some DexCom metrics that are commonly tracked and projected by analysts on Wall Street.
The consensus estimate for 'Revenue- Hardware' stands at $38.39 million. The estimate points to a change of -42.4% from the year-ago quarter.
The average prediction of analysts places 'Revenue- Sensor and other' at $978.78 million. The estimate indicates a year-over-year change of +14.6%.
Analysts predict that the 'Revenue- United States' will reach $709.42 million. The estimate points to a change of +8.6% from the year-ago quarter.
Analysts expect 'Revenue- International' to come in at $303.93 million. The estimate points to a change of +13.5% from the year-ago quarter.
Over the past month, shares of DexCom have returned +4.2% versus the Zacks S&P 500 composite's -0.8% change. Currently, DXCM carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Gear Up for DexCom (DXCM) Q1 Earnings: Wall Street Estimates for Key Metrics
The upcoming report from DexCom (DXCM - Free Report) is expected to reveal quarterly earnings of $0.33 per share, indicating an increase of 3.1% compared to the year-ago period. Analysts forecast revenues of $1.02 billion, representing an increase of 10.3% year over year.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
With that in mind, let's delve into the average projections of some DexCom metrics that are commonly tracked and projected by analysts on Wall Street.
The consensus estimate for 'Revenue- Hardware' stands at $38.39 million. The estimate points to a change of -42.4% from the year-ago quarter.
The average prediction of analysts places 'Revenue- Sensor and other' at $978.78 million. The estimate indicates a year-over-year change of +14.6%.
Analysts predict that the 'Revenue- United States' will reach $709.42 million. The estimate points to a change of +8.6% from the year-ago quarter.
Analysts expect 'Revenue- International' to come in at $303.93 million. The estimate points to a change of +13.5% from the year-ago quarter.
View all Key Company Metrics for DexCom here>>>
Over the past month, shares of DexCom have returned +4.2% versus the Zacks S&P 500 composite's -0.8% change. Currently, DXCM carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>